Symbiotec Pharmalab Ltd. Share Price

Overview

Symbiotec Pharmalab Ltd. share price is currently ₹1,120.00, up by ₹47.85 (4.46%) from its previous closing price of ₹1,072.15. The share price has gained 3.87% over the past month and gained 3.87% over the past year. The stock's 52-week low and high are ₹920.58 and ₹1,170.76, respectively. Symbiotec Pharmalab Ltd. has a market capitalisation of ₹ 6,930.00 Cr. The share price was last updated on 09 Sep 2026, 03:58 PM IST.

Symbiotec Pharmalab Ltd.

SYMBIOTEC

₹0.00

₹47.85

4.46%

Healthcare

₹0.00(%)1D

Updated: 09 Sep 2026, 03:58:56 pm IST

Market Data

Open Price

₹1,078.23

Prev. Close

₹1,072.15

₹1,061.15

Day Low

₹1,148.38

Day High

₹920.58

52 Week Low

₹1,170.76

52 Week High

HealthcarePharmaceuticals & Drugs

Category Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

63.93

Sector PE

42.03

PB Ratio

6.11

Sector PB

5.73

EPS

17.52

Dividend Yield

0.00

Today's Volume

3.518 M

5 Day Avg. Volume

2.112 M

PEG Ratio

-0.80

Market Cap.

₹ 6,930.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder	Jul 26 Shares held	Aug 26 Shares held
HDFC Pharma and Healthcare Fund - Regular Plan - Growth	-	4.05 Lac (100%)
Mahindra Manulife Small Cap Fund - Regular Plan - Growth	-	2.53 Lac (100%)
Tata Flexi Cap Fund - Regular Plan - Growth	-	1.58 Lac (100%)
Tata India Pharma & Healthcare Fund - Regular Plan - Growth	-	1.01 Lac (100%)
HDFC MNC Fund - Regular Plan - Growth	-	50.61 k (100%)

Show all holdings

About Symbiotec Pharmalab Ltd. 👋

Symbiotec Pharmalab Limited is an India-based research and development-driven, science-based pharmaceutical and biotechnology company. The Company operates through three platforms: organic chemistry, biotechnology and complex injectables. It manufactures its products using fermentation and multi-step complex chemical reactions. It has two operational industrial scale active pharmaceutical ingredients (API) manufacturing facilities: Rau, Mhow, Indore (Rau Facility) and Pithampur Special Economic Zone, Madhya Pradesh (SEZ Facility). It has a product portfolio of over 60 corticosteroid and steroidal-hormone APIs that are supplied globally, including Hydrocortisones, Betamethasones, Methylprednisolones, Progesterones, Estrogens and Testosterones. Its Rau Facility- Streoid products include Beclomethasone Dipropionate USP (Micronized & Non-Micronized), Betamethasone Dipropionate, Betamethasone Valerate, USP (Micronized), Clobetasol Propionate USP, Deflazacort Micronized and others.